BIOFORCE NANOSCIENCES HOLDINGS, INC (OTCMKTS:BFNH) Files An 8-K Other EventsItem 8.01- Other Information update
BioForce Nanosciences Holdings, Inc.’s Board of Directors consist of two directors, Mr. Merle Ferguson who is the Chairman of the Company, and also hold officer positions as CEO and President. Mr. Richard Kaiser is a Director and holds officer positions as Acting CFO and Corporate Secretary.
The Company’s office is located at 2020 General Booth Blvd, Unit 230, Virginia Beach, VA 23454, phone number 757-306-6090, email: [email protected].
Item 9.01 -Financial Statements and Exhibits.
(a)
Financial statements of business acquired. Not applicable.
(b)
Pro forma financial information. Not applicable.
(c)
Shell company transactions. Not applicable.
(d)
Exhibits-Not applicable
About BIOFORCE NANOSCIENCES HOLDINGS, INC (OTCMKTS:BFNH)
BioForce Nanosciences Holdings, Inc. owns, develops, acquires and/or licenses medical technological applications as they relate to the conventional and holistic healthcare industries. The Company develops and commercializes nanotechnology instruments, consumables and applications for the life sciences. Its products types include instrumentation, such as Nano eNabler Molecular Printing System, UV Ozone Cleaner-ProCleaner Plus and UV Ozone Cleaner-ProCleaner; surface patterning tools and accessories, including Surface Patterning Tools, SPT Holders and SPT Storage, and consumables, which include reagents, surfaces and tools. Its product applications include surface patterning applications, ViriChip Platform applications, biosensor applications, small volume biomolecular assays and business development. It offers vitamins and healthy diet programs for health food stores and nutritional education facilities. It provides consumable support products for atomic force microscopy. BIOFORCE NANOSCIENCES HOLDINGS, INC (OTCMKTS:BFNH) Recent Trading Information
BIOFORCE NANOSCIENCES HOLDINGS, INC (OTCMKTS:BFNH) closed its last trading session 00.0000 at 0.0200 with 20,000 shares trading hands.
